AsOf

Recorded or changed on this day 2026-11-08

1,951–2,000 of 46,537 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,871,000,000 United States dollar
Amgen quarterly revenue: 5,871,000,000 United States dollar, claim clm_0261B36A9FD9 · ended · superseded by clm_E2FB86DE7982 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 5,849,000,000 United States dollar
Amgen cash and equivalents: 5,849,000,000 United States dollar, claim clm_03B54912F3E2 · ended · superseded by clm_DA97E5CF2AF5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 758,861,306 shares
Amgen shares outstanding: 758,861,306 shares, claim clm_03C8CF5E3CB4 · ended · superseded by clm_C311BB3AF4EC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,453,000,000 United States dollar
Amgen quarterly operating income: 2,453,000,000 United States dollar, claim clm_03D15401052C · ended · superseded by clm_687CDFCB7970 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,592,000,000 United States dollar
Amgen quarterly revenue: 3,592,000,000 United States dollar, claim clm_0468DD568B92 · ended · superseded by clm_623DCF66B2AC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 539,708,274 shares
Amgen shares outstanding: 539,708,274 shares, claim clm_04AAD52EA082 · ended · superseded by clm_07D435B08217 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,257,000,000 United States dollar
Amgen cash and equivalents: 3,257,000,000 United States dollar, claim clm_05AF32DE89A0 · ended · superseded by clm_7A1F93F832FE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 563,265,902 shares
Amgen shares outstanding: 563,265,902 shares, claim clm_06A251E59EBC · ended · superseded by clm_BA677DC55A32 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,968,000,000 United States dollar
Amgen cash and equivalents: 2,968,000,000 United States dollar, claim clm_06EAF5224086 · ended · superseded by clm_099BDC522C6D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 537,706,118 shares
Amgen shares outstanding: 537,706,118 shares, claim clm_0715D8B97E5E · ended · superseded by clm_A337751C1DB4 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · employees · 17,900
Amgen employees: 17,900, claim clm_071977D99572 · valid · 2 sources (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 5,158,000,000 United States dollar
Amgen net income: 5,158,000,000 United States dollar, claim clm_071C52720059 · ended · superseded by clm_797A8E0010E4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 540,632,005 shares
Amgen shares outstanding: 540,632,005 shares, claim clm_07D435B08217 · ended · superseded by clm_E74CF4B58FED · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,293,000,000 United States dollar
Amgen quarterly operating income: 1,293,000,000 United States dollar, claim clm_087D410B4794 · ended · superseded by clm_010C5F53DEFB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 8,810,000,000 United States dollar
Amgen cash and equivalents: 8,810,000,000 United States dollar, claim clm_089D9CECF18D · ended · superseded by clm_C3AA215549F9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 14,349,000,000 United States dollar
Amgen total equity: 14,349,000,000 United States dollar, claim clm_08B4799386AF · ended · superseded by clm_84D402BD4390 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 582,168,612 shares
Amgen shares outstanding: 582,168,612 shares, claim clm_0909C448022C · ended · superseded by clm_3ED771217180 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 567,852,353 shares
Amgen shares outstanding: 567,852,353 shares, claim clm_096FA3E02484 · ended · superseded by clm_06A251E59EBC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,577,000,000 United States dollar
Amgen cash and equivalents: 3,577,000,000 United States dollar, claim clm_099BDC522C6D · ended · superseded by clm_3007B813C9B4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,623,000,000 United States dollar
Amgen quarterly net income: 1,623,000,000 United States dollar, claim clm_0A7CF5308206 · ended · superseded by clm_E3112AD96827 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 67,333,000,000 United States dollar
Amgen total assets: 67,333,000,000 United States dollar, claim clm_0AD0B0D546EB · ended · superseded by clm_4B925E62643E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 31,560,000,000 United States dollar
Amgen cash and equivalents: 31,560,000,000 United States dollar, claim clm_0B4F8228696C · ended · superseded by clm_ADA1FFC461F7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,000,000,000 United States dollar
Amgen cash and equivalents: 3,000,000,000 United States dollar, claim clm_0BA540E04C08 · ended · superseded by clm_16369A4AC42E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,311,000,000 United States dollar
Amgen quarterly net income: 2,311,000,000 United States dollar, claim clm_0C7BF65A9CC8 · ended · superseded by clm_2220944AC708 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 10,131,000,000 United States dollar
Amgen cash and equivalents: 10,131,000,000 United States dollar, claim clm_0DBEED486A33 · ended · superseded by clm_226AFDC7ECB0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 647,272,067 shares
Amgen shares outstanding: 647,272,067 shares, claim clm_0F1D20A7154A · ended · superseded by clm_709BAAA1A0C7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 92,504,000,000 United States dollar
Amgen total assets: 92,504,000,000 United States dollar, claim clm_109E7FAE5B37 · ended · superseded by clm_716046ECC37B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 9,674,000,000 United States dollar
Amgen operating income: 9,674,000,000 United States dollar, claim clm_10BA888AB580 · ended · superseded by clm_926C65AE4F09 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 1,774,000,000 United States dollar
Amgen cash and equivalents: 1,774,000,000 United States dollar, claim clm_10C37649975D · ended · superseded by clm_23946C33E856 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,677,000,000 United States dollar
Amgen cash and equivalents: 3,677,000,000 United States dollar, claim clm_10CF13C1B54A · ended · superseded by clm_BEC2DEF69723 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 4,207,000,000 United States dollar
Amgen cash and equivalents: 4,207,000,000 United States dollar, claim clm_1146A0E24CD4 · ended · superseded by clm_03B54912F3E2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,730,000,000 United States dollar
Amgen quarterly net income: 1,730,000,000 United States dollar, claim clm_12D32BFD074A · ended · superseded by clm_E9B14F8E9889 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 5,998,000,000 United States dollar
Amgen cash and equivalents: 5,998,000,000 United States dollar, claim clm_13EE0E401521 · ended · superseded by clm_787BD95A43CF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 26,323,000,000 United States dollar
Amgen revenue: 26,323,000,000 United States dollar, claim clm_142A6C7A0E55 · ended · superseded by clm_C49E0455CA9B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 63,997,000,000 United States dollar
Amgen total assets: 63,997,000,000 United States dollar, claim clm_1431EBB4BEA3 · ended · superseded by clm_47FB0FC871FE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,476,000,000 United States dollar
Amgen quarterly net income: 1,476,000,000 United States dollar, claim clm_14453E457A66 · ended · superseded by clm_7BC494395A3F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,477,000,000 United States dollar
Amgen quarterly operating income: 1,477,000,000 United States dollar, claim clm_148D97D70B0C · ended · superseded by clm_45C687484B85 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,517,000,000 United States dollar
Amgen quarterly operating income: 1,517,000,000 United States dollar, claim clm_14CFAC59EFA9 · ended · superseded by clm_CAB7E6C967C3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 7,258,000,000 United States dollar
Amgen operating income: 7,258,000,000 United States dollar, claim clm_14D79C128253 · ended · superseded by clm_92AC0DE5846F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 2,375,000,000 United States dollar
Amgen quarterly net income: 2,375,000,000 United States dollar, claim clm_159BCD3BFBBD · ended · superseded by clm_92C83000279C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 10,794,000,000 United States dollar
Amgen total equity: 10,794,000,000 United States dollar, claim clm_15DDEC9FE673 · ended · superseded by clm_348858F3E721 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,800,000,000 United States dollar
Amgen cash and equivalents: 3,800,000,000 United States dollar, claim clm_16369A4AC42E · ended · superseded by clm_2D8F2FC9E463 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,859,000,000 United States dollar
Amgen quarterly net income: 1,859,000,000 United States dollar, claim clm_17338F01F53F · ended · superseded by clm_BA7043500A6A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,764,000,000 United States dollar
Amgen quarterly revenue: 3,764,000,000 United States dollar, claim clm_17341E32AFF6 · ended · superseded by clm_D6A6F66C922D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 79,587,000,000 United States dollar
Amgen total assets: 79,587,000,000 United States dollar, claim clm_174E9062ADCC · ended · superseded by clm_643B856508E4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 534,930,850 shares
Amgen shares outstanding: 534,930,850 shares, claim clm_178FD19F2105 · ended · superseded by clm_C279B018E45E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 537,329,220 shares
Amgen shares outstanding: 537,329,220 shares, claim clm_17A7DEA15E83 · ended · superseded by clm_8727DF5F4982 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 9,673,000,000 United States dollar
Amgen total equity: 9,673,000,000 United States dollar, claim clm_183536BBBD61 · ended · superseded by clm_8CEE5F0631D9 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · total equity · 14,352,000,000 United States dollar
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 661,706,007 shares
Amgen shares outstanding: 661,706,007 shares, claim clm_185AD84BC290 · ended · superseded by clm_0F1D20A7154A · 1 source (1 primary) · conf 0.95

What the statuses mean